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ABSTRACT 
 
A retrospective study to assess the impact of hypertension on renal disease 
among renal patients in MIOT Hospitals, Chennai. The conceptual framework of the 
study was developed on the basis of epidemiological triad. The study variable was 
hypertension with renal disease patients attending renal outpatient department MIOT 
Hospitals, Chennai. A quantitative research approach with retrospective design was 
used to achieve the objectives of the study. The study was conducted in MIOT 
Hospitals, Chennai, with a sample size of 150 hypertension with renal disease 
patients. The samples were selected through purposive sampling method for 
prevalence of hypertension among renal patients and convenient sampling method for 
impact of hypertension on renal disease. The investigator used a demographic variable 
proforma and with clinical data and checklist on impact of hypertension on renal 
disease among renal patients to collect the data. The data collection tools were 
validated and reliability was established. The data was collected by using an interview 
method and from patient clinical file.  
The prevalence of Hypertension among renal patients is 451 hypertensive 
patients out of 1544 renal patients. The prevalence rate was 292.1 per 1000 renal 
patients. The demographic characteristics revealed that 36.7% of the patients were in 
the age group above 60 years and 64% of patients were male. It was noted that 62.7% 
of patients had moderate impact, 31.3% of patients had mild impact and 6% of 
patients had severe impact.78.2% of patients were not aware that hypertension leads 
to renal disease, 52% of patients have not consulted nephrologists for elevated urea 
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and creatinine, majority of them did not follow regular annual check-up( 78%), 68% 
of patients did not take antihypertensive drugs regularly. There is a significant 
association between the checklist score and demographic variables like gender, 
occupation and educational status (P< 0.05).  
The results indicated that hypertension has impact on renal disease. The 
increased blood pressure in renal disease also cause major cardiac problems among 
renal patients. So proper control of blood pressure and early detection can prevent 
major problem and increase the lifespan of hypertensive patients. 
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`CHAPTER I 
INTRODUCTION 
“Prevention is better than the cure” 
The bones can break, the muscle can atrophy, the glands can loaf, even the 
brain go into sleep without immediate danger for the survival, but if the kidney fails 
neither, the bone, the muscle, the gland nor the brain could carry on its function.  This 
statement underlies the importance of the kidney in our life.   
Hypertension  is  sometimes  called  “the  silent  killer  ” because the people  
who   have it  are  often are symptom  free.  In the  national  survey , 32%  of  the 
population who  had  pressures  exceeding  140/90  mm Hg,  were  unaware  of  their   
elevated blood pressure. It  should  be  monitored  at  regular  intervals  because  
hypertension  is  a silent killer which require careful attention.  
 An adult more than the age of 20 years who has a systolic blood pressure of 
equal or more than 140 mm Hg and a diastolic blood pressure of equal or more than 
90 mm Hg  when recorded on two occasions in a relaxed sitting posture  is considered 
hypertensive. 
Blood pressure should be measured in every adult. Hypertension is often 
asymptomatic. Currently persons with a blood pressure greater than 140/90 mm Hg 
are hypertensive; most with a systolic blood pressure of 120-140 mm Hg are said to 
be pre-hypertensive. The latter should be monitored because they are likely to develop 
hypertension. 
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Chronic kidney diseases are one of the most important chronic non-
communicable disease epidemics in the world, including India. Chronic kidney 
diseases have emerged as a serious public health problem worldwide. Health 
education is the cornerstone for prevention of chronic kidney disease. Public 
perception of chronic kidney disease and knowledge about kidney diseases is poor in 
India.  
Hypertension causes problems for many organs in the body, including the 
kidneys. Kidney problems caused by high blood pressure occur often in persons who 
have undetected, untreated, or poorly controlled hypertension. 
Many body systems are at serious risk due to the extreme rise in blood 
pressure. Multiple organs of the body, including the brain, the eyes, the blood vessels, 
the heart, and the kidneys may be damaged. The blood vessels of the kidney are 
highly susceptible to damage caused by high blood pressure, and kidney failure may 
develop and lead to permanent damage requiring long term dialysis. 
 Kidneys play a key role in keeping a person‟s blood pressure in a healthy 
range, and blood pressure, in turn, can affect the health of the kidneys. High blood 
pressure makes the heart work harder, and over the time, can damage the blood 
vessels throughout the body. If the blood vessels in the kidneys are damaged, they 
may stop removing wastes and extra fluid from the body. The extra fluid in the blood 
vessels may then raise blood pressure even more. This is a dangerous cycle. 
Chronic kidney disease is a long-term condition where the kidneys do not 
work as it is required to. The diseased kidneys do not usually produce any symptoms 
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until it has reached an advanced stage.  It is usually detected at earlier   stages by 
variations in the blood and urine tests only. So if it is detected early, the progression 
can be stopped or the disease can be reversed. 
High blood pressure is one of the leading cause of kidney failure. Every year, 
high blood pressure leads to more than 25,000 new cases of chronic kidney disease in 
the United States. 
Hypertension is a very common finding, particularly as people become older; 
it can also be the first sign of kidney disease. High blood pressure can also itself be a 
cause of kidney disease, so people who have high blood pressure for a number of 
years, particularly if it is difficult to control with medications, need to be repeatedly 
screened for evidence of kidney damage.             
Early chronic kidney disease does not cause symptoms. One should routinely 
evaluate asymptomatic persons who are at high risk for chronic kidney disease. 
Adults, especially those in the high-risk group with strong family history of diabetes, 
the obese and those with hypertension should be routinely screened for hypertension, 
diabetes and kidney disease.  
      The kidney is both a cause and victim of hypertension. High blood pressure is 
a key pathogenic factor that contributes to deterioration of kidney function. Presence 
of kidney disease is a common and underappreciated pre-existing medical cause of 
resistant hypertension. Therefore, treatment of hypertension has become the most 
important intervention in the management of all forms of chronic kidney disease. 
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   Nationally, 26 million adults have chronic kidney disease, more than 367,000 
people depend on dialysis for survival; 87,000 people are waiting for a Kidney 
transplant, and 75 percent of adults on dialysis cannot attend work or school, the 
spokesman said. 
      Chronic kidney disease is emerging as an important cause for morbidity and 
mortality. Worldwide, the major cause for chronic kidney disease is hypertension. In a 
country like India, where the per capita income is low, only 1% of the population can 
afford renal replacement therapy. The global response to this challenge is prevention, 
early detection, and treatment. 
      Nephrologists are highlighting the important role that chronic kidney disease 
plays in morbidity and mortality from cardiovascular disease, and they are stressing 
the importance of properly treating hypertension, diabetes, and dyslipidemia in 
patients with impaired renal function. 
     Hypertension in developing countries is often detected for the first time when 
the patients present with end organ damage. This observation may be related to the 
low level of awareness of hypertension. Just 8 % of the populations in Nigeria when 
compared to about 70 % in the US aware of their blood pressure status. 
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Need for the Study 
      Hypertension remains one of the leading causes for renal failure and is clearly 
a major contributor to accelerated loss of the renal function in the setting of other 
forms of the renal disease.  
Ashok.L, et al.(2011) stated the relationship between kidneys and 
hypertension. The kidneys are the regulators of blood pressure in normal body. When 
a person has renal hypertension, that hypertensive state itself induces 
histopathological changes of nephrosclerosis due to the hypertension and not due to 
the original renal disease. This nephrosclerosis adds to the renal damage produced by 
the renal disease and accelerates the process of azotemia. As a therapeutic maneuver, 
tight control of blood pressure helps to decelerate the process of azotemia and retards 
the progression of the renal failure towards end-stage. 
Levey.A.S,et al.(2011) sated the relationship between hypertension and kidney 
disease. No matter it is the kidney disease cause hypertension or just the reverse; 
blood pressure should be strictly controlled. First, choose those medicines that can 
control the blood pressure and at the same time can protect the kidneys. The blood 
pressure should be controlled at 130/80mm Hg. When the patients have severe 
proteinuria, the blood pressure should be controlled lower. Hypertension has become 
the most important cause of Uremia. There are not obvious symptoms for 
Hypertension so many patients will not know it until a test is done. Hypertension will 
lead to angiosclerosis of the heart and coronary heart disease, renal arteriosclerosis 
and renal artery stenosis, which will make hypertension more stubborn, that‟s why 
hypertension can‟t be effectively controlled.  
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Giusseppe Remuzzi, et al.(2008) stated that lack of awareness means that 
opportunities are being lost to prevent not only renal but cardiovascular diseases. 
Most important, kidney disease first needs to be identified, because of its silent nature, 
and the "simplest way to do this is to perform a dipstick test for proteinuria or to look 
at serum creatinine and see if there are any abnormalities."  
      Matthew.T, et al.(2008) on reviewing all the recent literatures with regard to 
chronic kidney disease, concluded: "The treatment of hypertension is the mainstay of 
management to slow the progression of renal disease and reduce cardiovascular risk. 
John fee Hally, et al.(2005) said that the government to Standardize the 
diagnostic testing for serum creatinine (an important measure of kidney function). To 
the people of the country he said, test yourselves periodically for albumin in the urine. 
Agarwal.R, et al.(2009) stated that hypertension is very common in patients 
with chronic kidney disease; its prevalence increases with glomerular filtration rate 
and reaches an estimated 86% in patients End Stage Renal disease. In the third 
national health and nutrition examination survey, 70% of those with an elevated 
serum creatinine had hypertension. Sodium and water retention with progressive 
decrease in glomerular filtration rate is thought to be etiologically related to the high 
prevalence of hypertension.  
Serum creatinine and blood urea levels are sensitive markers of kidney 
dysfunction. Measurement of serum creatinine and estimating the glomerular filtration 
rate is the recommended approach for early detection.  
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        The second approach to detect kidney dysfunction is by urinalysis in high-risk 
patients. The tests should include a urinalysis and if needed a urine-to-
protein/creatinine ratio measurement. In hypertensive and diabetic patients whom 
there is no Proteinuria, micro albuminuria is the earliest manifestation of kidney 
disease. 
The exact prevalence of chronic kidney disease in India is not clear in the 
absence of regular national registry data and provided only a small observational 
series or rely on reports from personal experience, but the quality of data is quiet 
uneven. There are only three population based studies in India commenting on the 
magnitude of chronic kidney disease.  
Nickolas.T.L, et al.(2004) conducted the study on awareness of kidney disease 
in the US population. The prevalence of end-stage renal disease in the US population 
has been predicted to increase by 48% during the next decade. Early identification and 
treatment of chronic kidney disease is necessary to delay progression from chronic 
kidney disease to end stage renal disease.  In participants with chronic kidney disease, 
40.5% of patients with stage 1, 29.3% of patients with stage 2, 22.0% of patients with 
stage 3, and 44.5% of patients with stage 4 chronic kidney disease were aware of their 
kidney disease, respectively. In multivariate regression modeling, lack of awareness 
was significantly associated with sex, race-ethnicity distribution, and hypertension. 
Kidney disease awareness is low among a representative sample of the 
noninstitutionalized U.S population. Groups at greater risk for kidney disease, such as 
patients with hypertension, and men, were more likely to be unaware of having 
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kidney disease. An increased effort to promote kidney disease awareness is needed 
and probably should target primary care providers involved in the screening process. 
In a prevention programme started at community level in Chennai, the 
reported prevalence is 0.86% in the project population and 1.39% in the control 
region. The second study is based on Delhi involving 4972 urban patients. The 
prevalence of chronic renal failure was found to be 0.79 % or 7852 per million 
populations. The third study perhaps the only longitudinal study to identify the 
incidence of end stage renal disease based on 572,029 subjects residing in city of 
Bhopal suggests that the average crude and age adjusted incidence rates of end stage 
renal disease were 151 and 232 per million populations respectively. 
The prevalence of hypertension is high in Kerala, South India. The prevalence 
of hypertension increases with older age, and high dietary salt intake. The low level of 
awareness of the problem among the population necessitates urgent medical and 
social intervention. Improvement of the awareness for hypertension and the early 
detection and treatment of high blood pressure in the community may reduce the risk 
of development of chronic kidney diseases. 
     The need for health care providers to be proactive with regard to the kidney 
disease by the early detection and treatment, with a view to slowing the progression is 
being increasingly emphasized worldwide.  
      Researcher has focused on importance of monitoring the renal function among 
hypertensive patients. 
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Statement of the Problem 
        A retrospective study to assess the impact of hypertension on renal disease 
among renal patients at MIOT Hospitals, Chennai. 
                                                            Objectives 
 To identify the prevalence of hypertension among the renal patients. 
 To identify the impact of hypertension on renal disease among renal patients. 
 To associate the renal failure checklist score with demographic variables of 
hypertensive patients with renal failure. 
Operational Definitions 
Impact 
    In this study, impact refers to the extent to which the effect of hypertension 
was the cause for renal disease in hypertensive patient. 
Hypertension      
     In this study, hypertension refers to persistent elevation of systolic blood 
pressure above 140mmhg and diastolic blood pressure above 90mmhg for prolonged 
period. 
Renal Disease 
In this study, renal disease refers to increased level of blood urea nitrogen and 
decreased glomerular filtration rate. 
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Renal patients 
 In this study, renal patients refers to the patient having renal disease and 
attending nephrology outpatient department.   
                                                       Assumptions 
 Hypertension is one of the risk factor for renal disease. 
 Hypertensive patients have an increased chance of developing renal disease. 
                                    
Delimitations 
 The study period was limited to 6 weeks only. 
 The study was delimited to only hypertensive patients with the renal disease 
and hypertensive patients attending nephrology outpatient department. 
Projected Outcome 
The study will increase the understanding about the impact of the hypertension on 
renal disease. Based upon the results of the study, the investigator can recommend the 
health care provider to advice annual renal function test for hypertensive patients to 
prevent the kidney disease at the earlier stage. 
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CHAPTER II 
REVIEW OF LITERATURE 
The review of literature refers to the activities involved in identifying and            
searching for information on the topic and developing and understanding the state of 
knowledge on the topic.                                       
  -Polit and Hungler[2004] 
   Literature review was done on prevalence of hypertension on renal disease, 
impact of hypertension on renal disease by means of extensive survey of books, 
journals, internet and media. Research as well as non-research literatures were 
reviewed to understanding and gain insight into the problem under study. It is 
gradually prepared to put a research problem in context or to identify gaps and 
weakness in prior studies so as to justify new investigations. An extensive review of 
relevant literature was conducted to generate an insight and collect maximum 
information for laying down the foundation of the study. 
The review of literature has been divided under the following headings: 
Section I: Literature related to prevalence of renal failure among the patient with     
                 hypertension.  
Section II: Literature related to impact of hypertension among the chronic kidney  
                   disease patients. 
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Section I 
Literature related to prevalence of renal failure among the patient with 
hypertension 
Information on the incidence and outcome of chronic kidney disease in India 
is not available. Unlike elsewhere in the world, there is no end-stage renal disease 
registry in India.  
Vimala.A, et al.(2009) conducted a large community-based study in South 
Delhi. The findings of the study revealed that the prevalence of chronic renal failure 
among adults was found to be 7850/million.
 
The prevalence of chronic renal failure is 
much higher in the western societies where the prevalence is estimated to be 
47000/million.  
Emeka.A.Nwankwo, et al.(2006) conducted the study on prevalence of 
impaired kidney function in hospitalized hypertensive patients in Maiduguri. He has 
compared 54 males and 31 females patients with impaired kidney function with that 
of 37 male and 63 female patients with normal kidney function.  The findings of the 
study revealed that among 50 hypertensive patients 27 % of study population had 
impaired kidney function. The mean serum creatinine in the study group was 289.2 
µmol/l with a standard deviation of 309.88 µmol/l. Elevated serum creatinine greater 
than 135 micromoles per liter was seen in 85 or 45.5 % of the study population.         
Mittal.S.K, et al.(2004) conducted the study on prevalence of hypertension in 
a hemodialysis population in Winthrop University Hospital, Mineola, New York. The 
samples include 190 patients. The pre/post mid-week dialysis blood pressure readings 
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of 190 patients (64+/-14.1 years, 53% males, 77% whites) were evaluated over a 3 
months period. Of the 190 patients, 146 (76.8%) were hypertensive. 117 out of 146 
hypertensive patients (80.1%) had persistent elevation of blood pressure despite being 
on one or more antihypertensive medications.39% of patients were on calcium 
channel blockers,27% being on beta-blockers and 14% on angiotensin converting 
enzyme inhibitors. There was no correlation between the number of medications used 
and the control of hypertension. The hypertension was a frequent finding in 
hemodialysis population and it was controlled in only 19.9% of hypertensive patients. 
Most of this hypertension was pre-dialysis systolic. There was a significant 
correlation between fluid loss during dialysis and lowering of blood pressure. 
Buckalew.V, et al.(2002) conducted a cohort study on prevalence of 
hypertension in chronic renal disease. In the study of the 1,795 patient with renal 
disease had adequately been on antihypertensive medications and were also assessed 
of their glomerular filtration rate and nutritional status. A total of 1,494 patients in this 
cohort were classified as hypertensive (83%) and the remainder (301 patients) as 
nonhypertensive. Ninety-one percent of the hypertensive subjects were on treatment, 
54% being controlled to a blood pressure of less than or equal to 140/90 mm Hg. 
Compared with normotensive subjects, hypertensive patients were older (51.2 +/- 12.7 
years v 46.6 +/- 13.1 years [mean +/- SD]), had a higher body mass index (BMI; 27.5 
+/- 4.7 kg/m(2) v 25.4 +/- 4.2 kg/m
2
), and had a lower GFR (37.8 +/- 19.6 
ml/min/1.73 m
2
 v 50.1 +/- 25 ml/min/1.73 m
2
). All these differences were significant 
(P < 0.01). The prevalence of hypertension was significantly higher for men than for 
women (86% v 80%; P = 0.001). 
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Crews.J, et al.(2002) conducted the study on prevalence of renal disease 
among U.S.adults. The findings revealed that 13.4% of people who have normal 
blood
 
pressure have chronic kidney disease. Among those with prehypertensive, the 
prevalence
 
was 17.3%; those with undiagnosed hypertension, the prevalence
 
was 
22.0%; and those with diagnosed hypertension, the prevalence
 
was 27.4%. Among 
adults in the United States, 1 in 4 has hypertension and
 
1 in 8 has chronic kidney 
disease as on the year 2000. 
The National Kidney and Urologic Disease Information, a federal agency 
(2001), estimates that about 4.5% of people over age 20 have chronic kidney disease, 
as indicated by tests that measure kidney function. Hypertension is the second leading 
cause of chronic kidney disease. It accounts for between 27% and 30% of all new 
cases of chronic kidney disease.  
Natalia Ridao, et al.(2001) conducted the study on prevalence of hypertension 
on renal disease in hospital General Universitario Gregorio Maranon, Madrid. The 
samples included in the study were 1921 patients with different nephropathies. The 
result revealed that the prevalence of hypertension in the total group of  patients with 
renal diseases was 60.5%, but this prevalence varied widely depending upon the type 
of underlying nephropathy. The prevalence of hypertension was practically universal 
in patients with renal vascular disease (93%) and in patients with established diabetic 
nephropathy (87%), and 74% of the patients with polycystic kidney disease, 63% of 
the patients with chronic pyelonephritis and 54% of the patients diagnosed with 
glomerulonephritis were Hypertensive. The prevalence of hypertension in patients 
with renal insufficiency (80%) is significantly higher than that in patients without 
15 
 
renal insufficiency (43% P<0.001). There is a high prevalence of hypertension in  
renal patients, which depends on the type of nephropathy and the degree of renal 
failure. 
Christine Adamec, et al.(2001) stated that renal failure is caused primarily by 
chronic high blood pressure  over many years. Hypertension is the second major cause 
of end stage renal disease after diabetes and is responsible for 25–30% of all reported 
cases. In addition, many people with diabetes also have hypertension, thus high blood 
pressure plays an even larger role in kidney failure. About 398,000 people were 
diagnosed with end stage renal disease in 2001. Of these, about 83,000 had 
hypertension and about 133,000 had diabetes.  
Udani, et al.(2000) conducted the study on epidemiology of hypertensive 
kidney disease, among U.S population. The findings revealed that, identifying the 
precise prevalence of chronic kidney disease attributable to hypertension is difficult 
owing to the absence of uniform criteria to establish a diagnosis of hypertensive 
nephropathy. Despite the increasing prevalence of chronic kidney disease associated 
hypertension, awareness of hypertension among individuals with chronic kidney 
disease remains suboptimal and rates of blood pressure control remain poor. Elevated 
blood pressure levels are associated with chronic kidney disease progression. 
Hypertension remains a common factor complicating chronic kidney disease. Future 
investigations identifying early signs of hypertension related chronic kidney disease, 
increasing awareness of the effects of hypertension in chronic kidney disease and 
determining optimal therapeutic interventions might help reduce the incidence of 
hypertensive nephropathy.  
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Coresh.J, et al.(2000) conducted the study on chronic kidney disease 
awareness, prevalence, and trends among U.S. adults. The findings of the study 
revealed that moderately decreased kidney function awareness was much lower 
among women than men (2.9 +/- 1.6 versus 17.9 +/- 5.9%; P = 0.008).  
Section II 
Literature related to impact of hypertension among chronic kidney disease 
patients 
Leoncini, (2011) belongs to I-DEMAND (Italy-Developing Education and 
awareness on microalbuminuria in patients with hypertensive Disease) conducted 
study on high blood pressure and cardiovascular prevention. The study was designed 
to assess the prevalence of microalbuminuria and its clinical correlates among Italian 
hypertensive patients. Samples were included 4151 patients from 87 specialized care 
centers. The study demonstrated that approximately one-half of the patients had 
chronic kidney disease, with albuminuria being present in one-quarter of the 
individuals. The presence of renal abnormalities was more prevalent in patients with 
concomitant cardiovascular risk factors. 
Eskridge.M.S, et al.(2010) conducted study on hypertension and chronic 
kidney disease, the role of lifestyle modification and medication management among 
U.S adults. The findings revealed that about one in three U.S. adults has high blood 
pressure, and despite this high occurrence, only one-third of patients are actually 
treated for high blood pressure. Reasons for this vary, but can include ineffective 
patient teaching, lack of understanding, poor lifestyle modifications, sub-optimal 
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treatment adherence, limited access to health care, or failure of healthcare providers to 
treat hypertension aggressively. There is a clear relationship between hypertension 
and chronic kidney disease.  
Koichi Hayashi, et al.(2010) conducted the study on impact of renal function 
on cardiovascular events in elderly hypertensive patients treated with efonidipine in 
Japan. The patients were randomly assigned to either a strict-treatment group (target 
systolic blood pressure < 140mm Hg, n=2212) or a mild treatment group (target 
systolic blood pressure 140 to <160 mm Hg, n=2206), each with efonidipine based 
regimens. Cardiovascular events were evaluated during the 2-year follow-up period 
following the prospective randomized open-blinded end-point method. Estimated 
glomerular filtration rate was elevated throughout the trial period in both the strict 
treatment group (59.4-62 mlmin
-1
 per 1.73m
2
) and the mild-treatment group (58.8-
61.4ml min
-1
 per 1.73m
2
). In conclusion, the rates of decline of renal function and 
proteinuria constitute critical risk factors for cardiovascular events in elderly 
hypertensive patients; trends that are enhanced when baseline estimated glomerular 
filtration rate is diminished. Furthermore, the fact that efonidipine based regimens 
ameliorate renal function in elderly hypertensive patients with chronic kidney disease 
may offer novel information on the mechanisms of cardiovascular protection. 
Agarwal.R, (2009) conducted the study on blood pressure components and the 
risk for end-stage renal disease and death in chronic kidney disease. A single-center, 
prospective cohort study was conducted on 218 veterans with chronic kidney disease 
(22% black, 4% women, mean age 68 yr, clinic blood pressure 154.1 +/- 25.1/85.2 +/- 
13.9 mm Hg, 48% with diabetes). During follow-up of up to 7 yr, 63 patients had end 
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stage renal disease and 102 patients died. Compared with those with controlled 
systolic blood pressure (<130 mm Hg), patients with moderate control (130 to 149 
mm Hg) had hazard ratio of 3.87 and those with poor control hazard ratio of 9.09 for 
end stage renal disease. Diastolic blood pressure had no direct ability to predict end 
stage renal disease. The study concluded that in older patients with chronic kidney 
disease, systolic blood pressure predicts end stage renal disease and a higher systolic 
blood pressure and lower diastolic blood pressure predicts all-cause mortality.  
Anthony Lee, et al.(2009) stated that, result of untreated high blood pressure is 
kidney failure. Along with diabetes mellitus, hypertension is a major risk factor for 
this condition because of the damage to the functional unit of the kidney. 
Additionally, such kidney disease, in turn, can increase blood pressure. Between 80 to 
90percentage of patients with chronic kidney failure have hypertension. 
Bakris.G.L, et al.(2009) stated on the world kidney day 2009, that the 
prevalence of chronic kidney disease continues to increase worldwide as does end 
stage renal disease. Chronic kidney disease is associated with a significant increase in 
cardiovascular risk. High blood pressure is a key pathogenic factor that contributes to 
the deterioration of kidney function. The presence of kidney disease is a common and 
underappreciated preexisting medical cause of resistant hypertension. Therefore, 
treatment of Hypertension has become the most important intervention in the 
management of all forms of chronic kidney disease. For this reason, world kidney day 
on March 12, 2009 emphasized the role of hypertension in prevention of renal 
disease. 
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Marin.R, et al.(2006) conducted the study on blood pressure control in patients 
with chronic renal insufficiency in Spain by a cross-sectional survey. The study was 
designed for assessment of control rates of blood pressure, proteinuria and 
cardiovascular co morbidities in patients with chronic renal insufficiency. 2501 
patients with a mean age 64.8 years (65.7% men) were included. The prevalence of 
previous cardiovascular disease was 55%. A poor blood pressure control was 
associated with older age, greater proteinuria and higher low-density lipoprotein 
cholesterol levels. Proteinuria greater than 0.5 g/day was observed in 1209 cases 
(48.3%). A total of 1899 patients (75.9%) were receiving drugs suppressing the 
activity of the renin-angiotensin system and 1048 patients (41.9%) were being treated 
with three or more antihypertensive drugs.  
Mogensen.C.E, et al.(2005) conducted the study on vascular impact of anti-
hypertensive treatment and renal protection. Hypertension contributes to the 
progression of renal disease by accelerating structural changes in the kidney, leading 
to a progressive decline in glomerular filtration rate. Hypertension and micro vascular 
changes can create a vicious circle, leading to further renal damage and increases in 
blood pressure. Angiotensin receptor blocking drugs and angiotensin converting 
enzyme inhibitors have been shown to display renoprotective effects and angiotensin 
converting enzyme inhibitors reduce the risk of microalbuminuria.  
Toto.R.D, et al.(2005) conducted a study on treatment of hypertension in 
chronic kidney disease. The findings revealed that chronic kidney disease is a major 
public health problem in the United States. Hypertension is present in more than 80% 
of patients with chronic kidney disease and contributes to progression of kidney 
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disease toward end stage as well as to cardiovascular events such as heart attack and 
stroke. Proteinuria is an important co-morbidity in hypertensive with chronic kidney 
disease and increase risk of disease progression and cardiovascular events. The 
National Kidney Foundation clinical practice guidelines recommend a blood pressure 
goal of less than130 mmHg systolic and less than 80 mmHg diastolic for all chronic 
kidney disease patients.  
Flack.J.M, et al.(2005) stated the prevention of hypertension and its 
complications in his study elevated blood pressure, particularly systolic blood 
pressure, has been linked to multiple adverse clinical outcomes including stroke, heart 
failure, myocardial infarction, renal failure, peripheral vascular disease, retinopathy, 
dementia, and premature mortality. In hypertensive persons with reduced kidney 
function and proteinuria, lowering blood pressure with multidrug therapy that is 
inclusive of pharmacologic modulators of the renin-angiotensin-aldosterone-kinin 
system is an effective strategy to forestall the progressive loss of kidney function. The 
totality of data support low therapeutic blood pressure targets for persons with 
proteinuria >1 gm/dl. 
Ryota.L, et al.(2005) stated that in renal parenchyma disease, several studies 
have stressed the impact of blood pressure and blood pressure-related vascular lesions 
on renal injury and outcome. However, more powerful independent clinical predictors 
of the renal outcome are elevated serum creatinine level at presentation and severe 
proteinuria. 
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Whitworth.J.A, et al.(2005) conducted the study on progression of renal 
failure in Annals Academy Of Medicine Singapore. He stated that High blood 
pressure plays a key role in the progression of renal failure. Hypertension is a 
common presentation of kidney disease and an almost invariable accompaniment of 
renal failure. Hypertension is also a major contributor to cardiovascular disease, the 
major cause of morbidity and mortality in renal failure. Hypertension is both cause 
and consequence of renal failure. There is strong evidence that hypertension 
accelerates the progression of experimental renal disease and that control of blood 
pressure is effective in preventing this progression. 
Garcia Cortes.M.J, et al.(2004) conducted the study on hypertension in 
hemodialysis patients in Andalucia. The study population included 2,789 hypertensive 
patients enrolled in 46 hemodialysis centers in Andalucia. Hypertensive patients were 
divided into 4 groups of severity according to the number of antihypertensive drugs 
received. Comparisons between groups were done. The results show that a 
hypertension prevalence of 53.8% in comparing clinical data of no hypertensive and 
hypertensive patients, we observed that patients with hypertension were significantly 
younger (60.2 +/- 15.6 vs.  63.5 +/- 15 years; P <0.001) and had shorter time on 
dialysis (months) (56.5 +/- 60 vs.  67.3 +/- 68.2; P = 0.001). Coronary heart disease 
(P< 0.001) and diabetes (P < 0.001) were associated with hypertension. 
De Nicola.L, et al.(2003) conducted the study on achievement of target blood 
pressure levels in chronic kidney disease. He stated that a large body of evidence 
supports the validity of lowering blood pressure to prevent cardiovascular disease in 
the general population. This issue becomes even more critical in renal patients 
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because they carry a greater cardio vascular risk across the entire spectrum of chronic 
kidney disease. In these patients, achievement of lower blood pressure levels also is 
fundamental to limit the progression of renal damage, especially in the presence of 
significant proteinuria. 
 Domenic.A, et al.(2003) stated that the impact of hypertension on highly 
vascular organs such as the kidney can be particularly devastating. Irrespective of the 
genesis of hypertension, the kidney becomes a target organ for hypertension-related 
damage. If hypertension goes untreated, renal failure progresses, and reaches end-
stage.  
Hall.J.E, et al.(2003) conducted study on impact of the obesity epidemic on 
hypertension and renal disease. He stated that excess weight gain is a major cause of 
increased blood pressure in most patients with essential hypertension, and also greatly 
increases the risk for renal disease. Obesity raises blood pressure by increasing renal 
tubular reabsorption, impairing pressure natriuresis, causing volume expansion due to 
activation of the sympathetic nervous system and renin-angiotensin system, and by 
physical compression of the kidneys, especially when visceral obesity is present. With 
prolonged obesity, there may be a gradual loss of nephron function that worsens with 
time and exacerbates hypertension. Weight reduction is an essential first step in the 
management of obesity hypertension and renal disease.  
Ljutic.D, et al.(2003) conducted the study on arterial hypertension in the 
progression of non-diabetic glomerular diseases. Glomerular hypertension results in 
glomerular capillary wall stretch, endothelial damage and a rise in protein glomerular 
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filtration. One of the most important factors in the progression of Chronic Renal 
Failure is activation of the rennin-angiotensin system. Its effect is not only elevated 
blood pressure, but also the promotion of cell proliferation, inflammation and matrix 
accumulation.  
Ronald.M, et al (2002) stated that hypertension can be related to chronic 
kidney disease in a number of ways. Studies show that the risk of having hypertension 
in chronic kidney disease patients is increased with advancing age, higher body 
weight. Increased activity of the sympathetic nervous system, causing an adrenaline 
surge. Hormonal mechanisms also play an important role in the link between chronic 
kidney disease and hypertension, primarily via the renin-angiotensin system; it 
contributes hypertension by stimulating salt retention and constriction of blood 
vessels. Para thyroid hormone that may raise blood pressure and has increased 
quantities with advancing chronic kidney disease. To slow the progression of chronic 
kidney disease and reduce the risk of heart disease controlling the blood pressure is 
important. Patients that lose a significant amount of protein in the urine are risk for 
progressive kidney disease and heart disease.  
Preston.R,et al.(2002) stated that most patients with renal parenchymal 
hypertension have sodium-sensitive hypertension, and, consequently, sodium 
restriction and loop diuretics constitute the initial steps in effective antihypertensive 
therapy in patients with renal disease. The loop diuretics (furosemide, ethacrynic acid, 
bumetanide, torsemide) are used for the management of extra cellular fluid volume 
hypertension in patients with renal disease because thiazide diuretics are generally not 
effective in patients with serum creatinine values above 2.0 mg/dl or creatinine 
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clearances below 30 ml/min. The Joint National Committee VI recommends the use 
of angiotensin-converting enzyme inhibitors in patients with hypertension and chronic 
renal disease to control hypertension and to slow progressive renal failure. 
Antihypertensive treatment with angiotensin-converting enzyme inhibitors may 
favorably alter renal hemodynamics, thereby slowing the progression of renal 
dysfunction.  
Jafer.T.H, et al.(2001) conducted the study on proteinuria as a modifiable risk 
factor for the progression of non-diabetic renal disease. Data were analyzed from 
1860 patients enrolled in 11 randomized controlled trials comparing the effect of 
antihypertensive regimens, including angiotensin converting enzyme inhibitors to 
regimens not including angiotensin converting enzyme inhibitors on the progression 
of non-diabetic renal disease. Mean baseline urine protein excretion was 1.8 (0.94) 
gm/day. After controlling for the current level of urine protein excretion, the 
beneficial effect of angiotensin converting enzyme inhibitors remained significant 
[relative risk for angioensin converting enzyme inhibitors vs. control was 0.66 (0.52 
to 0.83)], but there was no significant interaction between the beneficial effect of 
angiotensin converting enzyme inhibitors and the baseline level of urine protein 
excretion. 
Fujise.Y, et al.(2001) conducted the study on Comparison of the prognosis of 
hypertension associated with chronic glomerulonephritis with that of essential 
hypertension. The study findings reveals that prognosis of renal hypertensive was 
remarkably worse when it was compared with the prognosis of essential hypertensive. 
More than 80% of the essential hypertensive was still alive after ten years, while the 
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mortality rate of the renal hypertensive after 5 years was only 20%. In renal 
hypertension the survival rate was extremely low when the patients had high diastolic 
pressure, severe cardiac and cerebrovascular complication. The prognosis of essential 
hypertension was poor in the order of severe cerebrovascular complication, renal 
complication and cardiac complication. The patients with both renal and essential 
hypertension showed greater survival rate when the blood pressure was much more 
reduced by bed rest or antihypertensive drugs  
Lengani. A, et al.(2000) conducted the retrospective study on characteristics of 
renal disease in hypertensive morbidities in adults in Burkina Faso. 342 Hypertensive 
adults were included in the study (200 men, 142 women, mean age: 50.6 +/- 13.8 
years).The aim to determine the importance of renal disease in hypertensive (Blood 
pressure > 160/95 mmHg. Assessments were systematically done; blood pressure was 
183.6 +/- 36.4/113.3 +/- 23.1 mm Hg. Total morbidity concerned 316 patients 
(92.4%). Cardiovascular complications have been diagnosed in 236 patients (69%) 
with a mean age of 51.6 +/- 14 y, neurologic complications in 85 patients (24.9%, 
mean age: 55.7 +/- 12) and renal disease in 123 patients (36%; mean age: 44.7 +/- 
14.5 years). Patients under 40 years of age have had higher 24 hours proteinuria than 
other patients (1.05 +/- 1.17 g (n: 51) vs. 0.45 +/- 0.68 (n: 170), P < 0.01). Chronic 
renal failure occurred in youngest patients (n: 72, age: 39.7 +/- 13.4 vs. 53.7 +/- 12.3; 
P < 0.01) with a most high prevalence in rural (31.6%) than urban patients (15.8%; P 
< 0.01). In conclusion, data suggest that renal disease will be common cause of 
hypertension. 
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    Tesar.V, et al.(2000) stated the hypertension in diseases of the kidney. 
Patients with renal hypertension are threatened by cardiovascular complications of 
hypertension even more frequently than patients with essential hypertension. 
Hypertension is moreover an important factor in the progression of renal 
insufficiency. In the pathogenesis of renal hypertension an important role is played by 
sodium and fluid retention and activation of the renin-angiotensin system. Progression 
of rental insufficiency can be retarded only by more strict control of hypertension by 
angiotensin converting enzyme.  
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CONCEPTUAL FRAMEWORK 
                The conceptual framework deals with the inter- related concept that are 
assessable together in some rational schemes by virtue of their response to the 
common theme.                                                                               Polit & Beck( 2004). 
                 This chapter deals with conceptual framework adopted for this study. A 
conceptual framework is comprised of interrelated concepts of the natural 
phenomena. Epidemiology is the basis for disease prevention and health promotion. 
  Epidemiological information plays an important role in public health 
objectives aimed at promoting physical, mental, social well-being in the population. 
Epidemiological findings contribute to preventing and controlling disease by 
providing information that leads to informed public health policy and planning as well 
as individual health decision making. 
     During the present century, medical and social progresses have reduced the 
impact of infectious diseases on society and have increased public health concern with 
non-infectious chronic diseases. Difficulties have been encountered in applying the 
concept of agent to many of the chronic diseases. 
        Salt or sodium in the diet is also shown as possibly playing a role in causing 
Hypertension, although the evidence for the generality of this factor is far less certain 
than the public and most health professionals seem to believe. Higher blood pressure 
stresses the heart work too, can damage blood vessels throughout the body. If the 
blood vessels in the kidneys are damaged, they may stop removing wastes and extra 
fluid from the body. High blood pressure is one of the leading causes of kidney 
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failure. By looking at the next level above this, however, we find hypertension, which 
is a possible point for intervention. We can treat hypertension with an array of highly 
effective drugs. 
         Epidemiological triad helps to harvest the valid and precise information about 
the causes, preventions, and treatments for disease. The triad consists of an external 
agent, a host and an environment in which the host and agent are brought together 
causing the disease to occur in the host. 
      The triangle has three corners: 
 Agent that causes the disease 
 Host or organism harbouring the disease 
 Environment or those external factors that allow or cause disease  
  The mission is to break at least one of the sides of the triangle, disrupting the 
connection between the environment, the host and the agent and interrupting the 
continuation of disease. 
     The use of a settings framework is useful for conceptualizing and planning 
interventions and actions. Within each setting, a broad view is needed, and the 
epidemiological triad helps identify strategies for action. 
Agent 
      Hypertension caused by various factors including stress, sedentary lifestyle, 
aging, heart disease, kidney disease, vascular disease. Chronic hypertension leads on 
to permanent damage on kidney. 
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 In the kidneys there are changes both in glomeruli as well as end arteries, 
where in there is hyaline deposition, basement membrane thickening and narrowing of 
the capillary lumina which leads on to chronic kidney disease, owing to constant 
proteinuria, hematuria. 
Host 
Host factors are modifiable and non-modifiable. Modifiable risk factors 
includes life style modification, sedentary habits, individual attitudes, poor perception 
of blood pressure control, non compliance and is regular follow up, irregular 
monitoring the blood parameters like urea, creatinine.  
Non-modifiable factors includes age, gender, and genetics. 
Environment 
    Environment provides the „structure‟ within which people live and as such are 
powerful determinants of behaviours. Environment factors are internal and external. 
 Internal environment includes stress, hormonal changes, hereditary. 
External environment includes physical, economical status, socio cultural 
factors, non compliance of regular annual check-up, and non-compliance of drug 
therapy. 
      The components of the epidemiological triad are interconnected, but 
intervention strategies differ somewhat for each aspect of the triad. Host-related 
strategies tend to be educational (one-on-one education, behavioral interventions, 
public education) or medical (pharmaceutical, surgical). Vector-related solutions often 
are based in technology or engineering or otherwise modify the carrier or agent. 
30 
 
Environment-related solutions can be physical (changing structures and availability of 
goods, services, amenities), economic (influencing cost of goods and services and 
incomes to pay for them), policy oriented (altering the rules), and socio cultural 
(influencing attitudes, beliefs, and perceptions).  
Internal environment are stress, family history, hormonal changes. External 
environment are low socio economic status, non compliance of drug therapy, regular 
annual check-up 
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Figure: 1 Conceptual Framework based on Epidemiological Triad 
 
Impact of Hypertension on 
Renal Disease 
HOST 
    Modifiable 
a) Poor blood pressure control 
b) Non compliance to treatment 
modalities 
c) Irregular monitoring the 
blood parameters like urea, 
creatinine 
Non-modifiable 
Age, gender, genetics 
AGENT 
a) Uncontrolled hypertension 
b) Chronic hypertension 
c) Hypertensive renal disease 
d) Sedentary life style    
e) Aging 
f) Smoking  
g) Heart disease 
h) Stress   
 
ENVIRONMENT 
Internal environment 
Stress, hereditary, hormonal changes 
External environment 
a) Low socio economic status 
b) Non compliance of drug therapy 
and regular annual check-up 
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CHAPTER III 
 RESEARCH METHODOLOGY 
  Methodology of research refers to the investigation of the ways of obtaining, 
organizing and analyzing data. Methodological study addresses the development in 
validation and evaluation of research tools and methods.                           -Polit [2004] 
           This chapter deals with research approach, research design, setting, population,  
sampling, sample size, sampling technique, exclusion criteria, inclusion criteria, 
development and description of tool, validity, reliability, pilot study, data collection 
procedure, data analysis and protection of human rights. 
   The aims of retrospective study to assess the impact of hypertension on renal 
disease among renal patients in MIOT Hospital, Chennai. 
                                          Research Approach 
  The research approach used for this study was quantitative approach. 
                                                       Research Design 
  The retrospective research design was used for this study. 
Setting 
     The study was conducted in the nephrology outpatient department in the 
MIOT multispecialty Hospitals, Chennai. This hospital houses 450 beds and has 
sophisticated equipments. Nephrology outpatient department works between 9am to 
5pm from Monday to Saturday. Each day around 40-60 patients visit the nephrology 
outpatient department. In that renal failure with hypertension were many. 
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                                                Population 
      The population of this study was renal patients attending the nephrology 
outpatient department in MIOT Hospitals, Chennai.  
                                                     Sample 
     The sample was 150 patients with hypertension with renal failure in MIOT 
Hospitals, Chennai. 
  Sample Size 
    The sample size was 150 patients with hypertension and renal disease of both 
the genders. 
     Sampling Technique 
     Sampling technique used for finding the prevalence of hypertension among 
renal disease patients was purposive sampling method and convenient sampling 
method was used to assess the impact of hypertension. 
Inclusion Criteria 
 Renal patients attending nephrology outpatient department. 
 Patients who can understand Tamil and English. 
Exclusion Criteria 
 Patients not willing to participate in the study. 
 Renal patients with any other chronic illness.   
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Data Collection Tool 
Description of the Tool 
Part A 
Demographic profile of the patient. It includes age, sex, marital status, 
occupation, religion, educational status, diet pattern, place of residence, nationality, 
type of family, leisure time activity, habits, habits of regular exercise.  
Part B 
Section I: Clinical data includes, year of hypertension, year of renal disease, present 
and past blood pressure recording, symptoms, signs, cardiovascular system, 
respiratory system, gastrointestinal systems, central nervous system, lab investigation, 
impression, medical and non-medical management.  
Section II: Hypertension and Renal Disease related Checklist. The checklist with 15 
questions to assess the impact of hypertension among renal disease patients.      
 Scoring and interpretation: 
 Question no  1,2,9,10,12a,12b,12c12d,12e,12f,13 scores for ‘Yes’-0; ‘No’-1. 
Question no 3,4,5,6a,6b,6c,6d,6e,6f,7,8,11,14,15  scores for ‘Yes’-1; ‘No’-0 
Total score is 25; the score was interpreted as follows, 
 Mild impact             -     <50% 
 Moderate impact     -    51-75% 
 Severe  impact        -    76-100% 
35 
 
                                               Validity 
              Validity of the tool was obtained from experts in the field of Nursing and 
Nephrology. 
Reliability 
                The reliability of the tool was established through pilot study by inter rater 
testing method, the obtained score was r= 0.98. 
Pilot Study 
     In order to check the feasibility, reliability and practicability of the study, a 
pilot study was conducted after permission due for a period of one week from 
31.03.2011 to 5.04.2011. The study was conducted on 20 patients with hypertension 
and renal disease in Nephrology outpatient department at MIOT Hospitals, Chennai. 
The data was collected by the investigator using a clinical data and checklist. The 
result proved that the tool was valid and reliable.  
Data Collection Procedure 
           The data was collected for a period of 6 weeks from 31.05.2011to 09.07.2011. 
The data was collected from hypertensive with renal disease patients in MIOT 
Hospitals, Chennai. The permission to conduct the study was obtained from the 
institution and from the Head of the Department. The study population was renal 
disease patients attending the nephrology outpatient department. Time schedule for 
the study was planned to collect the data from the hypertensive with renal disease 
patients. The investigator initially established rapport with the hypertensive with renal 
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disease patients and the purpose of the study was explained. The informed consent 
was obtained from the hypertensive with renal disease patients. The prevalence of 
hypertension in renal disease patients was identified with patient’s clinical records by 
purposive sampling method. Through purposive sampling method the investigator 
identified 451 hypertensive patients in renal disease. Out of these identified patients 
the investigator selected 150 patients diagnosed to have hypertensive with renal 
disease by convenient sampling method. Interview method was used to ask question 
in demographic variables and checklist. Clinical data was identified from patient’s old 
records and clinical file. The data collection was done from 31.05.2011to 
09.07.2011(6 days per week) as per the following schedule: 
 
Weeks Number of samples 
1
st 
 Week 22 
2
nd
 Week 29 
3
rd
 Week 27 
4
th 
Week 24 
5
th
 Week 25 
6
th 
Week 23 
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Human Rights Protection 
      The pilot and main study were conducted only after approval of the research 
proposal by the college of nursing and the Institutional Ethical Committee. Also 
permission was obtained from the concerned Head of the Department to conduct the 
study. Informed consent was obtained from all the subjects who participated in the 
study. 
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CHAPTER IV 
DATA ANALYSIS AND INTERPRETATION 
Analysis is defined as the method of organizing data in such a way that the 
research questions can be answered. Interpretation is the process of making sense of 
the results and of examining the simplification of the findings with in a broader 
context.                                                                                             Polit & Beck(2004). 
This chapter deals with analysis and interpretation of the findings. The data 
were collected from the hypertension with renal disease patients to assess the 
prevalence of hypertension among renal disease patient and impact of hypertension on 
renal disease. 
The study findings are presented in the following sections. 
Section I      :  Prevalence rate of hypertension among renal disease patient. 
Section II     :   Distribution of sample according to the demographic characteristics. 
Section III   :   Distribution of impact of hypertension on renal disease.    
Section IV   :    Association between demographic variables and checklist score of 
                       hypertensive patients with renal disease. 
                                                    
 
 
 
39 
 
Section I 
This section presents prevalence of hypertension among renal disease patients. 
Table 1: Prevalence of hypertension among renal disease patients attending 
nephrology outpatient department. 
N=1544. 
          
  The above table shows that 1544 patients attended nephrology outpatient 
department during data collection period. Among them 451 patients had hypertension. 
Prevalence rate was estimated to be 292.1 per 1000 renal patients. 
                                                     
 
Weeks Total no of patients 
attended the outpatient 
department. 
Prevalence of  
hypertension among renal 
patients 
Percentage 
1
st
 Week 173                   55      31.79 
2
nd
 Week 328                                        98 29.88  
3 
rd
 Week 272                    76       27.9 
4
th
 Week 318                    89  28.0 
5
th
 Week 224                     61       27.2 
6
th
 Week 229                     72  31.4 
Total 1544                   451      29.21% 
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Sections II 
This section describes the demographic variables of hypertension with renal disease 
patients. 
Table 2: Distribution of demographic variables among renal patients. 
n=150 
S.No Demographic variables Frequency Percentage 
1. 
 
 
 
 
 
 
Age in years 
a) < 20 yrs 
b) 21 – 30 yrs 
c) 31 - 40 yrs 
d) 41 – 50 yrs 
e) 51 – 60 yrs 
f) > 60 yrs 
 
0 
6 
18 
31 
40 
55 
 
0.0 
 4.0 
12.0 
20.7 
26.7 
36.7 
2. 
 
 
Gender 
a) Male 
b) Female 
 
96 
54 
 
64.0 
36.0 
3. 
 
 
 
Marital status 
a) Married 
b) Unmarried 
c) Widow/Widower 
 
141 
5 
4 
 
94.0 
   3.3 
  2.7 
4. 
 
 
 
 
 
 
Occupational status 
a) Government employee 
b) Non Government employee 
c) Business 
d) Agriculture 
e) Unemployed 
f) Homemaker 
 
29 
34 
28 
7 
7 
45 
 
19.3 
22.7 
18.7 
  4.7 
  4.7 
30.0 
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5. 
 
 
 
 
Religion 
a) Hindu 
b) Muslim 
c) Christian 
 
 
134 
6 
10 
 
 
89.3 
 4.0 
 6.7 
6. 
 
 
 
 
 
 
Educational status 
a) Illiterate 
b) Primary 
c) Secondary school 
d) Higher Secondary 
e) Diploma 
f) Graduate & above 
 
8 
6 
15 
49 
10 
62 
 
 5.3 
 4.0 
10.0 
32.7 
 6.7 
41.3 
7. 
 
 
Diet pattern 
a) Vegetarian 
b) Non Vegetarian 
 
53 
97 
 
35.3 
64.7 
8. 
 
 
Residence 
a) Urban 
b) Rural 
 
125 
25 
 
16.7 
9. 
 
 
Type of family 
a) Nuclear family 
b) Joint family 
 
104 
46 
 
69.3 
30.7 
10. 
 
 
 
 
Leisure time activity 
a) Watching TV 
b) Gardening 
c) Reading books/newspaper 
 
147 
3 
60 
 
98.0 
  2.0 
40.0 
42 
 
 
Table  2 shows that 36.1% of the patients were above 61years of age , 64% 
were male, 94% of them were married; 41.3% were graduate, 64.7% were non-
vegetarian, most of them(69.3%) were nuclear family,32% of them were smokers, 
majority of the patients were not following the regular exercise.  
 
 
  
 
 
 
 
 
 
 
 
11. 
 
 
 
 
 
Habits 
a) Smoking 
b) Alcoholism 
c) Drug abuse 
d) Tobacco 
 
 
48 
25 
0 
4 
 
 
32.0 
16.7 
0.0 
2.7 
12. 
 
 
 
Habits of regular exercise 
a) Yoga 
b) Meditation 
c) Physical exercise 
 
3 
4 
12 
                 
2 
3 
8 
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Section III 
  This section presents the impact of hypertension on renal disease. 
Figure 2: Mean blood pressure value before and after diagnosis of renal disease 
among hypertensive patients. 
n= 150 
 
              
   Figure 2 shows that before diagnosis renal disease, mean systolic and 
diastolic blood pressure respectively were 156.33 and 93.60 mm Hg; after diagnosing 
renal disease mean systolic and diastolic blood pressure respectively were  168.27 and 
96.93.This shows that after renal damage the blood pressure is elevated. 
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Table 3: Changes of mean blood pressure before and after diagnosing renal 
disease among hypertensive patients. 
n=150 
 
Note: *** - P<0.001 Level of significant 
   
Table 3 shows that changes of blood pressure before and after diagnosing 
renal disease, systolic blood pressure mean was 11.93, standard deviation is 
20.94.Diastolic blood pressure mean was 3.33 and standard deviation was 9.60. 
Which was significant at P<0.001. 
 
 
 
Blood pressure Changes in blood pressure Paired t test and P 
value 
Mean Standard 
Deviation 
 
Systolic blood 
pressure 
 
 
11.93 
 
20.94 
 
t = 6.979, P = 0.000 
***  
Diastolic blood 
pressure 
 
3.33 9.60 t = 4.252, P = 0.000 
*** 
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Table 4: Distribution of sign variables among renal patients. 
n= 150 
 
S.No Sign variables      Frequency        Percentage 
 
1. 
 
 
 
Skin turgor 
a) Normal 
b) Abnormal 
 
 
125 
25 
 
 
83.3 
16.7 
2. 
 
 
Pallor 
a) Present 
b) Absent 
 
114 
36 
 
76.0 
24.0 
3. 
 
 
Jaundice 
a) Present 
b) Absent 
 
14 
136 
 
9.3 
90.7 
4. 
 
 
Edema 
a) Present 
b) Absent 
 
111 
39 
 
74.0 
26.0 
5. 
 
 
 
Cardiovascular system 
A)Heart sound 
a) Normal 
b) Abnormal 
 
 
145 
5 
 
 
96.7 
3.3 
 
 
 
B)Murmur 
a) Present 
b) Absent 
 
10 
140 
 
6.7 
93.3 
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Table 4 shows that 74% of patients had edema, 7.3% of patients had ascites. 
 
 
 
 
 
 
 
 
 
 
6. 
 
 
 
 
 
Respiratory system 
a) Rate 
b) Rhonchi 
c) Wheeze 
d) Any other 
 
 
18 
 5 
20 
1 
 
 
12.0 
  3.3 
13.3 
  0.7 
7. 
 
 
 
Gastrointestinal system 
a)  Abdominal distension 
b) Ascites 
c) Visceromegaly 
 
22 
11 
14 
 
14.7 
 7.3 
 9.3 
8. 
 
 
Central nervous system 
a)  Less Power of muscle strength 
b) Abnormal reflexes 
 
3 
2 
 
2.0 
1.3 
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Table 5:  Frequency distribution of symptoms among hypertensive patients with 
renal disease. 
 n= 150 
S.No Demographic variables Frequency Percentage 
 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
 
Generalized weakness 
Headache 
Tiredness 
Irritability 
Loss of concentration 
Giddiness 
Syncope 
Puffiness of face 
Swelling of legs 
Dyspnea 
Cough 
Loss of appetite 
Nausea & vomiting 
Abnormal bowel movement 
Reduced urine output 
Frothy urine 
 
137 
51 
105 
8 
6 
67 
15 
60 
112 
83 
32 
126 
101 
109 
83 
22 
 
91.3 
34.0 
70.0 
5.3 
4.0 
44.7 
10.0 
40.0 
74.7 
55.3 
21.3 
84.0 
67.3 
72.7 
55.3 
14.7 
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Table 5 shows that some of the patient are volume overloaded in that 40% of 
patient had facial swelling, 74.7% of patient had lib swelling.53.3% patient had 
reduced urine output, patient had urinary abnormalities in the form of 14.7% frothy 
urine and  hematuria 3.7%.   
 
 
 
 
 
 
 
 
 
 
 
 
17. 
18. 
 
Hematuria 
Epistaxis 
 
5 
2 
 
3.3 
1.3 
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Table 6: Association between systolic blood pressure with selected symptoms 
among renal patients.    
                n = 150 
 
Note: * - P<0.05 Level of Significant. 
  Table 6 reveals that there is a significant association between the systolic 
blood pressure, headache (P=0.047) and dyspnea (P=0.029). 
 
S.No Selected  
symptoms 
Symptoms response and systolic blood 
pressure 
Independent 
  t-test and  
  P – value 
No Yes 
Mean 
blood 
pressure 
Stantard
deviation
(n) 
Mean 
blood 
pressure 
Standard 
deviation 
(n) 
1. Generalized 
weakness 
162.3 17.4 (13) 168.8 20.0 (137)    t = 1.133 
   P = 0.259 
2. Headache 165.9 18.1 (99) 172.7 22.4 (51)    t = 2.033 
 P = 0.047 * 
3. 
 
Puffiness 
of  face 
167.1 18.1 (90) 170.0 22.2 (60)    t = 0.872 
   P = 0.385 
4. 
 
Swelling 
of legs 
165.2 16.6 (38) 169.3 20.8 (112)    t = 1.080 
   P = 0.282 
5. Dyspnea 164.3 15.9 (67) 171.4 22.1 (83)    t = 2.211 
P = 0.029 * 
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Table 7: Association between diastolic blood pressure with selected symptoms 
among renal patients. 
n =150 
 
Note: * - P<0.05 Level of Significant. 
Table 7 shows that there is a significant association between the diastolic 
blood pressure and headache (P=0.012). 
 
S.No Selected  
symptoms 
Symptoms response and diastolic blood 
pressure 
Independent  
t test and 
P – value 
No Yes 
Mean 
blood 
pressure 
Standard 
deviation 
Mean 
blood 
pressure 
Standard 
deviation 
(n) 
1. Generalized  
Weakness 
92.3 4.4 (13) 93.7 7.6 (137) t = 0.662 
P = 0.509 
2. Headache 92.5 7.7 (99) 95.7 6.1 (51) t = 2.539 
P = 0.012 * 
3. 
 
Puffiness 
of face 
93.7 7.4 (90) 93.5 7.3 (60) t = 0.136 
P = 0.892 
4. 
 
Swelling  
of legs 
93.2 7.0 (38) 93.7 7.5 (112) t = 0.428 
P = 0.669 
5. Dyspnea 93.4 6.6 (67) 93.7 7.9 (83) t = 0.249 
P = 0.803 
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Table 8: Descriptive statistics of clinical variables among renal patients. 
 n=150 
S.No Blood pressure       Mean  Standard 
 deviation 
Range  
    
Minimum 
  
Maximum 
 
1. 
 
Temperature 
 
98.51 
 
0.25 
 
97.8 
 
100.0 
2. Pulse Rate 84.12 5.62 62 102 
3. Respiratory Rate 24.00 5.78 20 30 
4. Systolic blood  
pressure 
168.27 19.86 140 250 
5. Diastolic blood 
pressure 
96.93 8.11 80 130 
6. Weight 62.52 10.67 36.4 91.6 
7. Height 160.80 7.99 143.0 182.0 
8. BMI 24.14 3.30 15.8 31.9 
 
   Table 8 shows that among all patients the weight ranges from 36.4 to 91.6 kgs 
and body mass index ranges from 15.8 to 31.9. Overweight patients had elevated 
blood pressure. 
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Table 9: Descriptive statistics of lab investigation variables among renal patients. 
n =150 
S.No Lab investigation 
variables 
Mean Standard      
deviation 
     Range 
      
Minimum 
      
Maximum 
 
1. 
 
Hemoglobin 
 
10.08 
 
1.90 
 
4.9 
 
14.7 
2. Packed cell volume 33.38 26.50 10.9 44.9 
3. White blood count 8145.99 2582.51 5260 18100 
4. Blood urea 90.13 32.91 42 191 
5. Serum creatinine 5.05 2.89 1.4 15.7 
6. Blood sugar 99.67 14.70 70 161 
7. Serum potassium 5.10 0.74 3.7 7.5 
8. Serum sodium 139.47 3.85 126 151 
9. Serum Calcium 8.84 0.71 5.7 10.3 
10. Serum phosphorus 4.90 1.12 3.1 9.3 
11. Serum chloride 105.53 5.44 90 119 
12. Serum bicarbonate 19.42 2.78 12 24 
13. Uric acid 6.69 1.76 3.6 13.2 
14. Serum total protein 7.04 0.59 5.4 8.2 
15. Serum albumin 3.77 0.44 2.5 4.9 
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Table 9 shows that patients have hemoglobin range from 4.9 to 14.7gm/dl, 
blood urea range from42 to 191 mg/dl, serum creatinine ranges from 1.4to 15.7 mg/dl, 
serum potassium ranges from 3.7 to 7.5 meq/l, and serum sodium ranges from 126-
151 meq/l. 
 
 
 
 
 
 
 
 
 
 
 
 
16. 
 
Serum globulin 
 
3.27 
 
0.50 
 
2.2 
 
4.6 
17. Serum total cholesterol 175.87 36.44 102 292 
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Table 10:  Correlation between lab investigations with blood pressure among 
renal patients. 
n =150 
 
Note: * - P<0.05 Level of Significant. 
    
Table 10 results that there is a significant association between the blood pressure and 
hemoglobin (0.028), packed cell volume (0.028), creatinine (0.018), calcium (0.002), uric 
acid (0.028), and total protein (0.028). There is a positive correlation between the blood 
pressure and creatinine (0.193). This implies that patient with uncontrolled hypertension 
will have high risk of elevated serum creatinine that is uncontrolled hypertension have 
proponderness in progression of renal failure.   
S.No Lab investigation Blood pressure 
Systolic blood pressure Diastolic blood 
pressure 
r – value P – value r – value P – value 
1. Hemoglobin -0.180 0.028* 0.050 0.540 
2. Packed cell volume -0.180 0.028* 0.050 0.540 
3. Urea 0.021 0.798 -0.064 0.439 
4. Creatinine 0.193 0.018 * 0.098 0.233 
5. Blood Sugar 0.010 0.901 -0.149 0.068 
6. Potassium -0.063 0.442 0.095 0.248 
7. Sodium -0.140 0.087 -0.117 0.155 
8. Calcium -0.250 0.002 ** -0.102 0.213 
9. Phosphorus 0.0 1.0 -0.046 0.576 
10. Uric acid -0.182 0.026 * -0.099 0.229 
11. Total  Protein -0.180 0.028 * -0.150 0.067 
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Figure 3: Distribution of urine test variables among renal patients 
n =150 
 
The figure 3 shows that 52.7% of patient have urine albumin 2+, 8.7% of 
patients have no albuminuria. Patients those lose a significant amount of protein in the 
urine are at somewhat higher risk, both for progression of kidney disease and heart 
disease. Currently, guidelines support a goal blood pressure less than 130/80 mm Hg 
for all patients with chronic kidney disease and less than 125/75mm Hg for those 
patients losing more than one gram of protein in the urine per day. 
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Table 11:  Distribution of radiological and imaging investigations among renal      
                                                        patients.                                                    n=150 
   
Table 11 shows that in ultrasound 83.3% of patients had shrunken kidney, 24.7% of 
patient had criteria qualifying for cardiac enlargement chest X-ray; of which 41.3% of 
patients had left ventricular hypertrophy in electrocardiogram continued 38.7% of 
patients had left ventricular hypertrophy in echocardiogram. 24.7% of patients had 
cardiac enlargement in chest X-ray. In ultrasound 83.3% of patients had shrunken 
kidney. This implies that hypertensive patients in renal disease have more chances of 
cardiac problems.  
S.No Radiological and  imaging Frequency Percentage 
 
1. 
 
 
 
Ultrasound – kidney size 
a) Normal 
b) Enlarged 
c) Shrunken 
 
18 
7 
125 
 
12.0 
4.7 
83.3 
2. 
 
 
Ultrasound – Liver 
a) Enlarged 
b) Not Enlarged 
 
39 
109 
 
26.0 
72.7 
3.  
 
 
Electrocardiogram 
a) Left ventricular hypertrophy 
b) Arrhythmias 
 
62 
5 
 
41.3 
3.3 
4.  
 
Echocardiogram 
a) Left ventricular hypertrophy 
 
58 
 
38.7 
5. 
 
 
Chest x-ray cardiac enlargement 
a) Present 
b) Not Present 
 
37 
113 
 
24.7 
75.3 
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Table 12: Distribution of treatment – non medical and medical management 
among renal patients. 
n =150 
 
     
 
S.No Management Frequency Percentage 
1. 
 
 
Stress management technique 
a) Yoga 
b) Meditation 
 
3 
3 
 
2.0 
2.0 
2. 
 
 
 
 
Fluid restriction per day 
a) 500 ml/day 
b) 1 lit/day 
c) 1.5 lit/day 
d) 2 lit/day 
 
6 
10 
116 
18 
 
4.0 
6.7 
77.3 
12.0 
3. 
 
 
 
 
Salt restricted diet 
a) No salt 
b) 1 gm 
c) 2 gm 
d) 3 gm 
 
8 
55 
80 
7 
 
5.3 
36.7 
53.3 
4.4 
4. 
 
 
Weight reduction technique 
a) Exercise 
b) Diet 
 
31 
149 
 
20.7 
99.3 
5. 
 
 
Life style modification 
a) Smoking cessation 
b) Avoid alcohol intake 
 
149 
150 
 
99.3 
100.0 
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Table 12 shows that most of the patients (85.3%) take calcium channel 
blockers. Many of them were taking calcium (86.7%), Iron (57.3%), and bicarbonate 
(77.3%) supplements. Almost all patients come for regular follow-up to renal 
outpatient department.  
 
 
6. 
 
 
 
 
 
 
Medical Management : 
Antihypertensive drugs: 
a) Alpha-1 adrenoceptor blocker 
b) Alpha-2 agonist 
c) Calcium channel blockers 
d) Angiotensin II receptor antagonist 
e) Beta blockers 
 
 
31 
25 
128 
14 
87 
 
 
20.7 
16.7 
85.3 
9.3 
58.0 
7. 
 
 
Calcium and  vitamin D supplements 
a) Yes 
b) No 
 
130 
20 
 
86.7 
13.3 
8. 
 
 
Iron supplements and erythropoietin drugs 
a) Yes 
b) No 
 
86 
64 
 
57.3 
42.7 
9. 
 
 
Bicarbonate supplements 
a) Yes 
b) No 
 
116 
34 
 
77.3 
22.7 
10. 
 
 
Regular follow up 
a) Yes 
b) No 
 
147 
3 
 
98.0 
2.0 
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Table 13:  Descriptive statistics on check list for hypertension with renal disease 
score among renal patients. 
n=150 
S.No Mean Standard 
deviation 
Range 
Minimum Maximum 
 
1. 
 
13.98 
 
3.15 
 
6 
 
21 
 
Table 13 shows that minimum range in checklist score was 6 and maximum 
score was 21. 
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Table 14: Distribution of check list responses. 
n=150 
Checklist 
questions 
Yes   No 
   Frequency      Percentage      Frequency     Percentage 
 
1. 
2. 
3. 
4. 
5. 
6a. 
6b. 
6c. 
6d. 
6e. 
6f. 
7. 
8. 
9. 
10. 
 
 
44 
32 
39 
76 
119 
57 
128 
48 
52 
85 
58 
112 
132 
72 
33 
 
 
29.3 
21.3 
26.0 
50.7 
79.3 
38.0 
85.3 
32.0 
41.3 
56.7 
38.7 
74.7 
88.0 
48.0 
22.0 
 
 
106 
118 
111 
74 
31 
93 
22 
102 
78 
65 
92 
38 
18 
78 
117 
 
 
70.6 
78.6 
74.0 
49.3 
20.7 
62.0 
14.7 
68.0 
58.7 
43.3 
61.3 
25.3 
12.0 
52.0 
78.0 
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  Table 14 shows that before diagnosing renal disease 70.8% of patients were 
not aware about hypertension and kidney disease, 78.2% of patients were not aware 
that hypertension leads to renal disease, 74.7% of patients had presence of albumin in 
urine, 88% of patients had elevated urea and creatinine, 52% of patients had not 
consulted nephrologists for elevated urea and creatinine, 78% of  patients did not 
come for regular annual checkup, 68% patients did not take antihypertensive drugs 
regularly. 
 
 
 
 
11. 
12a. 
12b. 
12c. 
12d. 
12e. 
12f. 
13. 
14. 
15. 
 
139 
49 
5 
20 
111 
118 
34 
82 
43 
12 
 
92.7 
32.7 
3.3 
13.3 
74.0 
78.7 
22.7 
54.7 
28.7 
8.0 
 
11 
101 
145 
130 
39 
32 
116 
68 
107 
138 
 
7.3 
67.3 
96.6 
86.7 
26.0 
21.3 
77.3 
54.3 
71.3 
92.0 
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Figure 4: Distribution of impact of hypertension on renal disease. 
n =150 
                    
 
 Figure 4 shows that 62.7% of patients had moderate impact, 31.3% of patients 
had mild impact, and 6% of patients had severe impact of hypertension on renal 
disease. 
31.30%
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6%
Mild impact
Moderate impact
Severe impact
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Figure 5: Distribution of impression on hypertension among renal patients. 
                 n=150 
 
          Figure 5 shows that all patients had hypertension with renal disease, 46.7% of 
patients had hypertension with cardiac problems. The result implies hypertension has 
more impact on renal disease as well as in cardiac problems. Renal patients should 
control their blood pressure to prevent cardiac problems. 
 
0
10
20
30
40
50
60
70
80
90
100
HT&Renal 
Disease.
HT&Cardiac 
problems
HT&CNS 
problems
100
46.7
2.7
64 
 
Section IV 
This section deals the association between demographic variables with checklist 
score. 
Table 15: Association between level of check list score and demographic      
                 variables among hypertensive patients with renal disease.           n =150 
S.No Demographic  
variables 
Mild 
impact 
(<50%) 
Moderately 
impact 
(51-75%) 
Severe 
impact 
(>75%) 
Chi 
square 
test and P 
value 
No % No % No % 
 
1. 
 
 
 
 
 
 
Age in years 
b) 21 – 30 yrs 
c) 31 - 40 yrs 
d) 41 – 50 yrs 
e) 51 – 60 yrs 
f) > 60 yrs 
 
 
1 
5 
9 
9 
23 
 
 
16.7 
27.8 
29.0 
22.5 
41.8 
 
 
5 
12 
21 
26 
30 
 
 
83.3 
66.7 
67.7 
65.0 
54.5 
 
 
0 
1 
1 
5 
2 
 
 
0.0 
5.6 
3.2 
12.5 
3.6 
 
 
χ 2=8.751 
d.f. = 8 
P=0.364 
2. 
 
 
Gender 
a) Male 
b) Female 
 
21 
26 
 
21.9 
48.1 
 
66 
28 
 
68.8 
51.9 
 
9 
0 
 
9.4 
0.0 
χ 2 = 
14.251 
d.f= 2 
P=0.001 
*** 
3. 
 
 
 
Marital status 
a) Married 
b) Unmarried 
c) Widow 
 
44 
2 
1 
 
31.2 
40.0 
25.0 
 
88 
3 
3 
 
62.4 
60.0 
75.0 
 
9 
0 
0 
 
6.4 
0.0 
0.0 
 
χ 2 =0.85 
d.f. = 4 
P=0.932 
65 
 
 
4. 
 
 
 
 
 
 
 
Occupation 
a) Govt. employee 
b)Non Govt. 
employee 
c) Business 
d) Agriculture 
e) Unemployed 
f) Homemaker 
 
 
12 
8 
4 
0 
2 
21 
 
 
41.4 
23.5 
14.3 
0.0 
28.6 
46.7 
 
 
16 
23 
21 
6 
5 
23 
 
 
55.2 
67.6 
75.0 
85.7 
71.4 
51.1 
 
 
1 
3 
3 
1 
0 
1 
 
 
3.4 
8.8 
10.7 
14.3 
0.0 
2.2 
 
 
χ 2 =19.28 
d.f. = 10 
P=0.037 * 
5. 
 
 
 
Religion 
a) Hindu 
b) Muslim 
c) Christian 
 
43 
2 
2 
 
32.1 
33.3 
20.0 
 
82 
4 
8 
 
61.2 
66.7 
80.0 
 
9 
0 
0 
 
6.7 
0.0 
0.0 
 
χ 2 =2.058 
d.f. = 4 
P=0.725 
6. 
 
 
 
 
 
 
Educational status 
a) Illiterate 
b) Primary 
c) Secondary school 
d) Higher  Secondary 
e) Diploma 
f) Graduate & above 
 
3 
1 
3 
16 
1 
23 
 
37.5 
16.7 
20.0 
32.7 
10.0 
37.1 
 
3 
5 
11 
29 
7 
39 
 
37.5 
83.3 
73.3 
59.2 
70.0 
62.9 
 
2 
0 
1 
4 
2 
0 
 
25.0 
0.0 
6.7 
8.2 
20.0 
0.0 
 
 
χ =18.877 
d.f. = 10 
P=0.042 * 
7. 
 
 
Diet pattern 
a) Vegetarian 
b) Non Vegetarian 
 
21 
26 
 
39.6 
26.8 
 
31 
63 
 
58.5 
64.9 
 
1 
8 
 
1.9 
8.2 
 
χ 2 =4.336 
d.f. = 2 
P=0.114 
8. 
 
 
Residence 
a) Urban 
b) Rural 
 
43 
4 
 
34.4 
16.0 
 
75 
19 
 
60.0 
76.0 
 
7 
2 
 
5.6 
8.0 
 
χ 2= 3.302 
d.f. = 2 
P=0.192 
66 
 
 
Note: * - P<0.05, Level of significant. 
 
Table 15 results shows that there is a significant association between checklist 
score with gender (p =0.001), occupation (p =0.014) and educational status (p-0.042). 
There is no association between other demographic variables and checklist score. 
 
 
 
 
 
9. 
 
 
 
Type of family 
a) Nuclear family 
b) Joint family 
 
 
30 
17 
 
 
28.8 
37.0 
 
 
69 
25 
 
 
66.3 
54.3 
 
 
5 
4 
 
 
4.8 
8.7 
 
χ 2= 2.206 
d.f= 2 
P=0.332 
11. 
 
 
 
 
Leisure time activity 
a) Watching TV 
b) Gardening 
c) Reading      
books/newspapers 
 
 
45 
0 
19 
 
 
30.6 
0.0 
31.7 
 
 
94 
3 
39 
 
 
63.9 
100.0 
65.0 
 
 
8 
0 
2 
 
 
5.4 
0.0 
3.3 
 
 
χ 2 = 3.99 
d.f. = 2 
P=0.136 
12. 
 
 
 
Habits 
a) Smoking 
b) Alcoholism 
d) Tobacco 
 
13 
4 
1 
 
27.1 
16.0 
25.0 
 
 
29 
14 
3 
 
 
60.4 
56.0 
75.0 
 
 
6 
7 
0 
 
 
12.5 
28.0 
0.0 
 
 
χ 2 = 2.55, 
d.f. = 2 
P=0.279 
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CHAPTER V 
DISCUSSION 
 The aim of the retrospective study was to assess the prevalence of 
hypertension among renal patients and the impact of hypertension among renal 
patients. Sampling method used for finding the prevalence of hypertension among 
renal disease patients was purposive sampling method and convenient sampling 
method was used to assess the impact of hypertension.  
Table  (2) shows that 36.1%t of the patients were above 61years of age , 64% 
were male, majority of them were married ( 94%); 41.3% were  graduate, 64.7% were 
non-vegetarian, 69.3% of them were nuclear family, 32% of them were smokers, 
majority of the patients were not following the regular exercise. It shows that 
hypertension and renal disease are more common among male patients.  
The first objective of the study was to identify the prevalence of the 
Hypertension among the renal patient 
Table (1) shows that 1544 patients attended nephrology outpatient department 
during data collection period. Among them 451 patients had hypertension. Prevalence 
rate was estimated to be 292.1 per 1000 renal patients. 
The findings are consistent with the study done by Natalia Ridao et.al (2001) 
on prevalence of hypertension in renal disease in Hospital General Universitario 
Gregorio Maranon, Madrid. The study findings revealed that the prevalence of 
hypertension in 1921 patients with different nephropathies. The prevalence of 
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hypertension in the total group of  patients with renal diseases was 60.5%, but this 
prevalence varied widely depending upon the type of underlying nephropathy. The 
prevalence of hypertension was practically universal in patients with renal vascular 
disease (93%) and in patients with established diabetic nephropathy (87%), and 74% 
of the patients with polycystic kidney disease, 63% of the patients with chronic 
pyelonephritis and 54% of the patients diagnosed with glomerulonephritis were 
hypertensive. The prevalence of hypertension in patients with renal insufficiency 
(80%) is significantly higher than that in patients without renal insufficiency (43% 
P<0.001). There is a high prevalence of hypertension in renal patients, which 
depends on the type of nephropathy and the degree of renal failure.  
    The second objective of the study was to identify the impact of the 
Hypertension on renal disease among patient. 
   In the year between 1996-2000, 22.7% of patients were diagnosed as 
hypertension, 30% of patients were diagnosed as hypertension in the year between 
2001-2006. 62% of patients were diagnosed as renal disease in the year between 
2006-2010. 
Figure (2) shows that, before diagnosis renal disease, mean systolic and 
diastolic blood pressure respectively were 156.33 and 93.60 mm Hg; after diagnosing 
renal disease mean systolic and diastolic blood pressure respectively were 168.27 and 
96.93 mm Hg. This shows that after renal damage the blood pressure is elevated. 
Table (3) shows that blood pressure before and after diagnosing renal disease. 
The change in blood pressure comparing  before and after diagnosing renal disease 
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shows that systolic blood pressure mean M= 11.93 and standard deviation SD= 20.94. 
Diastolic blood pressure mean was 3.33 and standard deviation 9.60, t- value was 
most significant at (P=0.000) level. The blood pressure was significantly increased 
after diagnosing renal disease. 
Table (4) shows that 74% of patients had edema, 7.3% of patients had ascites. 
Table (5) shows that some of the patient are volume overloaded in that 40% of 
patient had facial swelling, 74.7% of patient had lib swelling. 53.3% patient had 
reduced urine output, patient had urinary abnormalities in the form of 14.7% frothy 
urine and  hematuria 3.7%.   
Table (6) results revealed that there is a significant association between the 
systolic blood pressure and headache (P=0.047) and also association between the 
dyspnea (P=0.029). 
Table (7) shows that there is a significant association between the diastolic 
blood pressure and headache (P=0.012). 
Table (8) shows that, among all patients the weight ranges from 36.4 to 91.6 
kgs and body mass index ranges from 15.8 to 31.9. Overweight patients had elevated 
blood pressure. 
Table (9) shows that patients have hemoglobin range from 4.9 to 14.7gm/dl, 
blood urea range from42 to 191 mg/dl, serum creatinine ranges from 1.4to 15.7 mg/dl, 
serum potassium ranges from 3.7 to 7.5 meq/l, and serum sodium ranges from 126-
151 meq/l.  
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Table (10) shows that there is a significant association between the blood 
pressure and hemoglobin (0.028), packed cell volume (0.028), creatinine (0.018), 
calcium (0.002), uric acid (0.028), and total protein (0.028). There is a positive 
correlation between the blood pressure and creatinine (0.193). This implies that 
patient with uncontrolled hypertension will have high risk of elevated serum 
creatinine that is uncontrolled hypertension have proponderness in progression of 
renal failure.   
The figure (3) shows that 52.7% of patient have urine albumin 2+, 8.7% of 
patient have no albuminuria. Patients those lose a significant amount of protein in the 
urine are at risk for progressive kidney disease and heart disease. Currently, 
guidelines support a goal blood pressure less than 130/80 mm Hg for all patients with 
chronic kidney disease and less than 125/75mm Hg for those patients losing more 
than one gram of protein in the urine per day. 
Table (11) shows that in ultrasound 83.3% of patients had shrunken kidney, 
24.7% of patient had criteria qualifying for cardiac enlargement chest X-ray; of which 
41.3% of patients had left ventricular hypertrophy in electrocardiogram continued 
38.7% of patients had left ventricular hypertrophy in echocardiogram. 24.7% of 
patients had cardiac enlargement in chest X-ray. In ultrasound 83.3% of patients had 
shrunken kidney. This implies that hypertensive patients in renal disease have more 
chances of cardiac problems.  
Table (12) shows that most of the patients (85.3%) take calcium channel 
blockers. Many of them were taking calcium (86.7%), Iron (57.3%), and bicarbonate 
(77.3%) supplements. Almost all patients come for regular follow-up to renal 
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outpatient department. Medications are certainly essential in the treatment of 
hypertension, especially in chronic kidney disease, but lifestyle changes patients can 
bring profound impact on their blood pressure and general health. 
The Investigator felt that ‘kidney disease is common, harmful, and treatable’. 
Presence of proteinuria has been affecting the adult population. Chronic kidney 
disease progress to end stage renal disease and renal abnormalities are associated with 
a many-fold increase in risk of cardiovascular complications and premature 
cardiovascular deaths. Chronic kidney disease is treatable because there is strong 
scientific evidence that early detection, altering lifestyle factors and aggressively 
controlling blood pressure, cannot only slow or halt the progression of patients with 
chronic kidney disease to end stage renal disease but significantly reduce the 
incidence of cardiovascular disease.  
The conceptual framework formulated for the study was the epidemiological 
triad model. This model focused that uncontrolled hypertension, chronic hypertension, 
smoking, stress, non compliance of treatment modalities, non compliance of regular 
annual checkup, Irregular monitoring the blood parameters like urea, creatinine. 
Uncontrolled hypertension has more impact in renal disease. Hypertension should be 
controlled to retard renal disease progression and prevent cardiac problems. 
Table (13) shows that minimum range in checklist score was 6 and maximum 
score was 21. 
Table (14) shows that, before diagnosing renal disease 78.2% of patients were 
not aware that hypertension leads to renal disease, 74.7% of patients had presence of 
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albumin in urine, 88% of patients had elevated urea and creatinine, 52% of patients 
had not consulted nephrologists for elevated urea and creatinine, 78% patients did not 
come for regular annual checkup, 68% patients did not take antihypertensive drugs 
regularly. 
 Figure (4) shows that 62.7% of patients had moderate impact, 31.3% of 
patients had mild impact, and 6% of patients had severe impact of hypertension on 
renal disease. 
Figure (5) shows that all patients had hypertension with renal disease, 46.7% 
of patients were hypertensive with cardiac problems. The result implies that 
hypertension has more impact on renal disease as well as in cardiac problems. Renal 
patients should control their blood pressure to prevent cardiac problems. Lowering 
blood pressure will reduce the risk of heart disease, which for most patients with 
chronic kidney disease. 
The findings can be supported by Lengani.A, et al (2000) conducted the 
retrospective study on characteristics of renal disease in hypertensive morbidities in 
adults in Burkina Faso. 342 hypertensive adults were included in the study (200 men, 
142 women, mean age: 50.6 +/- 13.8 years).The aim was to determine the importance 
of renal disease in hypertensive (blood pressure > 160/95 mm Hg) clients. 
Assessments were systematically done; blood pressure was 183.6 +/- 36.4/113.3 +/- 
23.1 mm Hg. Total morbidity concerned 316 patients (92.4%). Cardiovascular 
complications have been diagnosed in 236 patients (69%) with a mean age of 51.6 +/- 
14 years, neurologic complications in 85 patients (24.9%, mean age: 55.7 +/- 12) and 
renal disease in 123 patients (36%; mean age: 44.7 +/- 14.5 y). Patients under 40 years 
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of age had higher 24 hours proteinuria than other patients (1.05 +/- 1.17 g (n: 51) vs. 
0.45 +/- 0.68 (n: 170), P < 0.01). Chronic renal failure occurred in youngest patients 
(n: 72, age: 39.7 +/- 13.4 vs. 53.7 +/- 12.3; P < 0.01) with a most high prevalence in 
rural (31.6%) than urban patients (15.8%; P < 0.01). In conclusion, data suggest that 
renal disease is a common cause of hypertension. 
Investigator felt that kidney disease and end stage renal disease have reached 
epidemic proportions and are becoming an unbearable burden on the health care 
resources of the individual and society. The investigator suggested that steps like 
organizing education program with the help of mass media  using different strategies 
of Information Education Communication (pamphlets, posters, health education, 
video seminar) can create awareness among the general public with kidney disease, 
life style modification, control of blood pressure, diabetes etc, training health workers 
in primary health centers to check for risk factors like hypertension and diabetes, 
awareness campaigns at work facilities, hospitals, and unions etc.in cities, 
standardizing labs and make reporting of estimated Glomerular filtration rate 
mandatory, emphasis in the medical and nursing curriculum and campaign to educate 
the medical and nursing fraternity about chronic kidney disease are few feasible and 
cost effective program that can tackle this issue. A public private participation in these 
programs, with the government taking the lead will further enhance its effectiveness. 
The only hope is the knowledge that early detection and treatment of chronic kidney 
disease can dramatically reduce the progression to end stage renal disease and also the 
risk of cardiovascular disease.  
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The third objective of the study was to associate the renal failure checklist 
score with selected demographic variables among hypertensive patients with 
renal disease. 
         Table (15) shows that, there is a significant association between checklist 
score with gender (P =0.001), occupation (P=0.014) and educational status (P=0.042). 
There is no association between other demographic variables and checklist score. 
The findings are consistent with Julie.A,
 
et al (2011) conducted the study on 
associations among perceived and objective disease knowledge in patients with 
chronic kidney disease. Survey method used among 399 chronic kidney disease 
patients. Demographically, the patient median age was 58 years, 47% were women, 
77% had stages 3–5chronic kidney disease, and 83% were Caucasians. The overall 
median score of the perceived knowledge survey was 2.56 (range: 1–4). Older age, 
male gender, and limited health literacy were associated with lower perceived 
knowledge. The findings were patients with chronic kidney disease have a limited 
understanding of their illness. 
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CHAPTER VI 
SUMMARY, CONCLUSION, LIMITATIONS, IMPLICATIONS 
AND RECOMMENDATIONS 
         This chapter presents the summary and conclusion of the study, the implication 
for nursing practice and recommendations for further study. 
Summary 
A retrospective study to assess the impact of hypertension on renal disease among 
renal patients at MIOT Hospitals, Chennai, during the year 2011. 
        The following objectives were  
 To   identify the prevalence of the hypertension among the renal patients. 
 To identify the impact of the hypertension on renal disease among renal 
patients. 
 To associate the renal failure checklist score with demographic variables 
among hypertensive patients with renal failure. 
               The conceptual framework of the study was epidemiological triad. A 
retrospective research design was adopted for this study; the population consisted of 
renal patients those were attending the renal outpatient department. 
  Sampling method used for fining the prevalence of hypertension among renal 
disease patients was purposive sampling method and convenient sampling method 
was used to assess the impact of hypertension. The tool used for data collection was 
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clinical data related to renal problem and checklist related to hypertension and renal 
disease. 
 Descriptive statistics (frequency, percentage, mean and standard deviation 
and chi square) and Inferential statistics (paired t test and correlation) were used. 
The study findings were as follows 
 Prevalence of hypertension among renal patients was 292.1 per 1000. 
 Distribution of sample was according to demographic variables. 
 Among 150 patients 62.7% of patients had moderately impact, 31.3% of 
patients had   mild impact, and 6% of   patients had severe impact. This shows 
hypertensive patients should have adequate measure to prevent and early 
diagnosis of renal disease. 
 There was a significant association between checklist score with gender 
(P=0.001), occupation also significant with checklist score (P =0.014) and 
educational status. 
Conclusion 
Hypertension is the main cause of renal disease. Most of the people were not 
aware of impact of hypertension in renal disease and they did not followed standard 
precaution for prevention of renal problems. Hypertensive patients should follow the 
regular annual check-up and do urea, creatinine, and urine albumin tests to detect the 
renal disease in early stage. Regular follow up to nephrologists may prevent death and 
cardiac problems. Blood pressure usually increase after the diagnosis of renal disease. 
It leads to cardiac problems, end stage renal disease and stroke. Therefore, blood 
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pressure control is important among renal disease patients. The investigator fulfilled 
this role by imparting knowledge through distributing pamphlets to each of the patient 
of her study. 
Limitations 
 The study findings were restricted to hypertensive with renal disease patients.  
 Data collection period was limited to 6 weeks only hence the long term 
benefits of the study could not be evaluated. 
 The sample size was limited to 150 only which restricts generalization. 
                                           Nursing Implications 
The findings of the study has implications in different branches of nursing 
profession i.e., nursing practice, nursing education, nursing research and nursing 
administration. 
Nursing Practice 
 Chronic kidney disease is the major health problem in worldwide. 
Hypertension is the major risk factor for these problems.  
 Hypertension is the common problem in India so nurses should create 
awareness among people that hypertension is the cause and main sign of renal 
disease. Nurses are responsible to teach the  methods of early detection and 
prevention of renal problems. 
 Awareness should be created among the people regarding the impact of 
hypertension in kidney and heart diseases. 
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 Nurses should make awareness among the hypertensive people regarding the 
regular urea, creatinine, urine protein check up and early diagnosis of renal 
disease and to consult Nephrologists regularly and carry out lab investigations 
to prevent the progression of renal disease. 
 
Nursing Education 
 Students and Nurse Educators can conduct health awareness programme on 
early detection of renal disease among hypertensive patients. 
 Students can conduct mass education program in community regarding regular 
check up and control of hypertension. 
 Nursing curriculum should develop stress compliance for treatment of 
hypertension and renal disease.  
Nursing Administration 
 The Nursing Administrator should know about impact of hypertension on 
renal disease. 
 The Nursing Administrator should encourage and provide facilities to conduct 
health education among the public regarding regular check up and control of   
hypertension. 
 The Nursing Administrator should recommend the government to strictly 
enforce hypertensive control to prevent renal disease. 
 The Nursing Administrator should encourage and conduct research regarding 
hypertension and renal disease in large population groups.  
 The Nursing Administrator should enforce the importance of urine albumin 
checking among hypertensive patients regularly to detect kidney disease early.   
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Nursing Research 
 This study can be effectively utilized by emerging researchers. Nurse 
researcher should come forward to conduct research in early detection of renal 
disease and should create awareness in blood pressure control among renal 
disease patients. 
 The finding of the study may help to expand knowledge upon which further 
researches can be conducted. Nurse researchers should conduct research 
among hypertensive patients regarding awareness of renal disease. 
Recommendations 
 Similar study can also be conducted in community settings. 
 Comparative study can be conducted among different age group.  
 The study could be replicated in different setting with similar facilities. 
 Comparative study can be conducted among people who have diabetes and 
hypertension. 
 A similar study can be conducted by prospective method among hypertensive 
patient. 
 The research can be conducted among people who are taking medications for 
chronic diseases like diabetes mellitus, hypertension etc. 
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APPENDIX A 
Letter seeking permission to conduct the study 
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APPENDIX B 
                                                  Informed consent form 
I am A. Rengalakshmi , M.Sc.Nursing student studying at MIOT College of 
Nursing, Chennai. 
As a part of my studies a research on “A Retrospective study to assess the 
impact of hypertension on renal disease among renal patients” at MIOT 
Hospitals Chennai. The findings of the study will be helpful for further information 
regarding early diagnosis of renal disease and importance of treatment among 
hypertensive patient. 
I hereby seek your consent and co-operation to participate in the study. Please 
be frank and honest in your response. The information collected will be kept 
confidentially and anonymity will be maintained. 
Signature of the investigator. 
 
I  ____________________________________________, hereby give my consent to 
participate and undergo the study. 
Place:   
Date :                                   Signature of the Participant 
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APPENDIX C 
TOOL 
                                                         PART A 
DEMOGRAPHIC VARIABLES OF THE PATIENT 
 
1.      Age 
a) < 20years  
b) 21-30years  
c) 31-40years 
d) 41-50years  
e) 51-60years 
f) >61years 
  2.    Gender 
a) Male  
b) Female            
  3.    Marital status 
a) Married  
b) Unmarried  
c) Widow/ Widowers 
4.     Occupation 
a) Government employee 
b) Non -Government employee 
c) Business   man  
d) Agriculture 
e) Unemployed  
f) Homemaker 
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5.     Religion 
a) Hindu 
b) Muslim  
c) Christian 
 
d) Any other 
6.     Educational status 
a) Illiterate 
b) Primary school  
c) Secondary school 
d) Higher secondary  
e) Diploma  
f) Graduate and above 
7.     Diet pattern 
a) Pure Vegetarian 
b) Non-vegetarian 
8.    Place of residence 
a) Urban  
b) Rural  
9.   Type of family 
a) Nuclear family  
b) Joint family 
10.   Leisure time activity 
a) Watching TV  
b) Gardening 
c) Reading books/ Newspapers  
d) Any other specify 
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11.    Habits 
a) Smoking  
b) Alcoholism  
c) Drug abuse  
d) Tobacco   
e)  Any other  
f)  None of the above 
12.    Habit of regular exercise  
a) Yoga  
b) Meditation  
c) Physical exercise  
d) Others 
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PART B---SECTION-1 
CLINICAL DATA OF HYPERTENSIVE WITH RENAL DISEASE PATIENT 
Year of hypertension:                                            
Year of renal disease:  
Blood pressure –Present:                           Past: 
Symptoms of hypertensive patient with renal disease 
S.NO Symptoms Yes No 
 
1. 
 
Generalized weakness 
  
2. Headache   
3. Tiredness   
4. Irritability   
5. Loss of concentration   
6. Giddiness   
7. Syncope   
8. Puffiness of face   
9. Swelling of legs   
10. Dyspnea   
11. Cough   
12. Loss of appetite   
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13. 
 
Nausea & vomiting  
  
14. Abnormal bowel movement   
15. Reduced urine output      
16. Frothy urine   
17. Hematuria   
18. Epitaxis   
19. Any other   
 
Signs of hypertensive patient with renal disease 
S.NO Signs  
 
1. 
 
Temperature 
 
2. Pulse rate  
3. Respiratory rate  
4. Blood pressure-systolic and diastolic  
5. Skin turgor  
6. Pallor  
7. Jaundice  
8. Edema  
9. Weight  
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10. 
 
Height 
 
11. BMI  
12. Cardiovascular system 
a) Heart sounds 
b) Murmur 
c) Any other 
 
13. Respiratory system 
a) Rales 
b) Rhonchi 
c) Wheeze 
d) Any other 
 
14. Gastrointestinal system 
a) Abdominal distention 
b) Ascites 
c) Visceromegaly 
d) Bruit renal 
 
15. Central nervous system 
a) Power of muscle strength 
b) Reflexes 
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Lab investigation 
S.NO Investigation Values 
I.     Blood counts 
1) Hemoglobin 
2) Packed cell volume 
3) White blood count  
 
II.   Bio chemical values 
1) Blood urea 
2) Serum creatinine 
3) Blood sugar 
4) Serum potassium 
5) Serum sodium 
6) Serum calcium 
7) Serum phosphorus 
8) Serum chloride 
9) Serum bicarbonate 
10) Serum total protein 
 Albumin 
 Globulin 
       11)Serum total cholesterol 
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III. Urine test 
1) Urine albumin 
 
 
Radiological and imaging investigation 
S.NO Radiological and imaging investigation  
I. 
 
 
 
 
 
 
 
 
Ultrasonography 
1.kidney size    
a) Normal  
b) Enlarged  
c)  Shrunk                 
2.Liver 
a) Enlarged 
b)  Not enlarged 
3.Ascites 
a) Present 
b)  Not present 
 
II. Electrocardiogram 
a) Left ventricular hypertrophy 
b) Arrhythmias 
 
III. Echocardiogram 
a) Left ventricular hypertrophy  
b)  Ejection fraction 
c)  Pericardial effusion 
d)  Left atrium enlargement 
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IV. Chest x-ray  
a) Cardiac enlargement 
 
 
Impression 
S.NO Impression Yes No 
1. 
2. 
3. 
Hypertension and renal disease 
Hypertension and cardiac problems 
Hypertension and central nervous system problem 
  
Treatment 
Non-medical management 
1) Stress management technique 
a) Yoga 
b) Meditation 
2) Fluid  restriction per day  
a) 500ml/day  
b) 1lit/day  
c) 1.5lit/day 
d) 2lit/day 
3) Salt restricted diet  
a) 1gm  
b) 2gms 
c) 3gms 
d) 4gms 
4) Weight reduction technique 
a)  Exercise 
b) Diet 
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5) Life style modification 
a)  smoking cessation 
b)  Avoid alcohol intake 
Medical management 
1) Antihypertensive drugs 
a) Alpha-1 adrenoceptor blocker 
b) Alpha-2 agonist 
c) Calcium channel blockers 
d) Angiotensin II receptor antagonist 
e) Beta blockers 
2) Calcium supplements 
a) Yes 
b) No 
3) Iron supplements and Erythropoietin drugs 
a) Yes 
b) No 
4) Bicarbonate supplements 
a) Yes 
b) No 
5) Regular follow-up 
a) Yes 
b) No 
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SECTION II 
HYPERTENSION WITH RENAL DISEASE RELATED CHECKLIST 
S.NO QUESTIONS YES  NO 
1.  Do you know about hypertension and kidney disease?   
2.  Do you know that hypertension leads to kidney disease?   
3.  Do any of your family members have kidney disease due 
to hypertension? 
  
4.  Do you have any stress in your job before diagnosing 
hypertension? 
  
5.  Do you have elevated blood pressure whenever you 
checked before the diagnoses of kidney disease? 
  
6.  Do you have any of these signs and symptoms before 
diagnosing kidney disease?  
           a) Early morning Headache 
           b) Edema(especially in face) 
           c) Less urine output 
           d) Breathing difficulty 
           e) Dry skin 
           f) Weight gain 
  
7.  Do you have presence of albumin (or) protein in your 
urine before diagnoses of kidney disease? 
  
8.  Do you have elevated blood urea and creatinine level 
before diagnose of kidney disease? 
  
9.  Have you ever consulted nephrologists for treatment of 
increased serum urea and creatinine levels? 
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10.  Do you go for regular annual health check up after 
diagnosing hypertension disease? 
  
11.  Do you think kidney disease can be diagnosed in earlier 
stage because of regular annual health checkup? 
  
12.  Do you follow the below mentioned instructions after 
diagnosing hypertension? 
a. Salt restricted diet 
b. Fluid restricted diet 
c. Low fat diet 
d. Avoid alcohol intake and caffeine  
e. Quit smoking 
f. Regular weight check-up 
  
13.  Do you take antihypertensive drugs regularly before 
developing kidney disease? 
  
14.  Have you ever developed uncontrolled hypertension and 
admitted or received treatment for it? 
  
15.  Have you ever developed hypotension due to 
antihypertensive drugs? 
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INTRODUCTION. 
High blood pressure is a common condition 
among renal patients that can lead to serious 
complications such as strokes, cardiac problems 
and End Stage Renal Disease(ESRD). Therefore, 
blood pressure control is important factor to 
prevent complications among renal patients. 
BENEFITS OF BLOOD PRESSURE 
CONTROL AMONG RENAL PATIENT. 
                                                
 
 
 
 
 
 Helps to slow the progression of renal 
disease. 
 
 Decreases the incidence of cardiac 
problems and stroke among renal disease 
patients.  
 Helps to reduce the protein loss through 
urine. 
STEPS TO CONTROL THE BLOOD 
PRESSURE.  
 Steps to control the blood pressure by making 
lifestyle changes. 
1. Dietary Modification: 
 Eating fresh fruits, vegetables, low-fat, 
and fiber rich diet. 
 
 
 
 Reducing the salt intake of 2gm/day or 
less than 2gm/day, avoiding salty foods 
like pickles, packed tinned item and fast 
foods. 
 Reducing caffeine intake. 
    2. Work modification: 
 Avoid heavy lifting. 
 Avoid stressful job. 
  3. Exercise: 
 Reducing excess weight. 
 Increasing physical activity such as 
walking, swimming or cycling and 
exercising regularly. 
 
. 
 
BENEFITS AND STEPS TO 
CONTROL THE BLOOD 
PRESSURE. 
 
  
 
  
 
 
 
 
 
 
  
4. Stress reduction (Relaxation) technique: 
 
 
 
 
 Meditation. 
 Yoga. 
 Biofeedback. 
 Progressive muscle relaxation. 
 Psychotherapy. 
 
5. Changing habits: 
 Quitting alcohol and smoking. 
 Avoiding tobacco products. 
  
6. Compliance to treatment: 
 
 
 
 Monitoring regular blood pressure and 
(intake of antihypertensive drugs if 
required). 
 Regular treatment modalities and follow 
up. 
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